Australian shares were again flat on Tuesday after oil prices eased from a one-month high point on reports of potential de-escalation in the Middle East conflict.
The S&P/ASX 200 Index was little changed to close at 8,793.30.
Brent crude oil futures fell nearly 1% to trade around $88 per barrel. An Iranian official said the country had received a proposal from mediators for a 10-day ceasefire, Reuters reported. This was despite the Houthis in Yemen saying they would impose a naval blockade on major oil producer Saudi Arabia.
Spot gold rose nearly 1% to $4,045.65 per ounce.
On the domestic front, the ANZ-Roy Morgan Australian consumer confidence rose 0.3 points to 75.6 in the week of July 13 to July 19, ANZ reported.
Australian consumer confidence edged higher last week, with improved sentiment around major household purchases largely offset by "weaker confidence in personal finances and the economic outlook," according to ANZ economist Sophia Angala.
In company news, NEXTDC's (ASX:NXT) pro-forma contracted utilization increased 11% since April 20 to 740 megawatts as of June 30 following additional customer contract awards. The company's pro forma forward order book increased to 565 megawatts due to contract wins.
Telix Pharmaceuticals (ASX:TLX) reported second-quarter revenue rose 21% to $247 million due to strong sale of precision medicine category. The company expects fiscal 2026 income to track in line with the upper end of the outlook of $950 million to $970 million.
Lastly, PYC Therapeutics (ASX:PYC) said autosomal dominant optic atrophy (ADOA) patients in the ongoing clinical trials of its PYC-001 drug candidate showed sustained improvement in both visual acuity and retinal stress following repeat doses.